Search results

1. Improving the therapeutic potential of cytostatics through the use of abiotic metallacarboranes.

Principal investigator: Michalina Gos

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: PRELUDIUM 23, Panel: NZ7

2. The role of cancer stem cells in extracellular matrix production and drug resistance in ovarian cancer

Principal investigator: dr hab. Radosław Januchowski

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

Call: SONATA BIS 6, Panel: NZ5

3. Combined targeted therapy with the use of PPAR receptor ligands or statins and cytostatics aimed at molecular mechanisms…

Principal investigator: dr Wojciech Stanisław Placha

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: SONATA 1, Panel: NZ4

4. Photodynamics of metal complexes with 2,6-bis(thiazol-2-yl)pyridine derivatives functionalized by aryls and N-donors as …

Principal investigator: dr Anna Maria Maroń

UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

Call: SONATA 16, Panel: ST4

5. New strategies in cancer therapy - bioinorganic conjugates of cytostatics and boron clusters.

Principal investigator: dr hab. Tomasz Marek Goszczyński

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATA 12, Panel: NZ1

6. Mechanism regulating vitamin D analog cooperation with cytostatics and tyrosine kinase inhibitors in non-small cell lung…

Principal investigator: dr Ewa Agnieszka Maj

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: PRELUDIUM 5, Panel: NZ4

7. Development of analytical methods for investigation of ionomic equilibrium in tumour cells under the exposure of metallo…

Principal investigator: dr hab. Katarzyna Monika Pawlak

Politechnika Warszawska, Wydział Chemiczny

Call: OPUS 5, Panel: ST4

8. Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk…

Principal investigator: dr hab. Bożena Anna Tyliszczak

Politechnika Krakowska im. Tadeusza Kościuszki

Call: OPUS 28, Panel: ST8

9. Design and characterisation of sealing materials of prosthetic obturator being additionally a cytostatic drug reservoir.…

Principal investigator: prof. Anna Trusek

Politechnika Wrocławska

Call: OPUS 26, Panel: ST8

10. Research on white-rot fungi ability to remove cytostatic drugs on an example of: bleomycin and vincristine

Principal investigator: dr Marcelina Karolina Jureczko

Politechnika Śląska, Wydział Inżynierii Środowiska i Energetyki

Call: PRELUDIUM 19, Panel: ST8

11. The impact of anti-cancer therapies on genetic stability of chondrocytes differentiated from human pluripotent stem cell…

Principal investigator: dr Ewelina Stelcer

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

Call: PRELUDIUM 12, Panel: NZ7

12. Developing of a new system for targeted anticancer therapy based on betulin derivetive and self-organizing polymeric nan…

Principal investigator: prof. Janusz Edward Kasperczyk

Śląski Uniwersytet Medyczny w Katowicach, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu

Call: HARMONIA 7, Panel: ST5

13. Evaluation of the CRNDE gene expression and the impact of its newly discovered protein product on selected aspects of tu…

Principal investigator: Anna Balcerak

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

Call: PRELUDIUM 9, Panel: NZ5

14. Biocompatible polymeric nanocapsules as anticancer drug delivery system

Principal investigator: dr Joanna Monika Szafraniec

Uniwersytet Jagielloński, Wydział Chemii

Call: PRELUDIUM 9, Panel: ST5

15. Multifunctional nanocarriers for theranostics and their interactions with light

Principal investigator: prof. Kazimiera Anna Wilk

Politechnika Wrocławska, Wydział Chemiczny

Call: OPUS 3, Panel: ST4

Projects search